Torrent Pharmaceuticals rose 3.06% to Rs 758.50 at 10:23 IST on BSE after consolidated net profit jumped 72% to Rs 256 crore on 15% increase in revenues to Rs 1114 crore in Q1 June 2014 over Q1 June 2013.
The result was announced after trading hours on Wednesday, 30 July 2014.
Meanwhile, the BSE Sensex was down 10.35 points, or 0.04%, to 26,077.07.
On BSE, so far 22,000 shares were traded in the counter, compared with an average volume of 25,785 shares in the past one quarter.
The stock hit a high of Rs 785 so far during the day, which is also a record high for the counter. The stock hit a low of Rs 752.80 so far during the day. The stock hit a 52-week low of Rs 385.95 on 22 August 2013.
The stock had outperformed the market over the past one month till 30 July 2014, rising 3.71% compared with 2.65% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 27.48% as against Sensex's 16.37% rise.
The large-cap pharmaceutical company has an equity capital of Rs 84.61 crore. Face value per share is Rs 5.
Torrent Pharmaceuticals' EBITDA (earnings before interest, taxes, depreciation and amortization) rose 66% to Rs 345 crore in Q1 June 2014 over Q1 June 2013. EBITDA margin increased to 31% in Q1 June 2014 compared with 21% in Q1 June 2013.
Revenues of domestic formulation business grew 13% to Rs 356 crore in Q1 June 2014 over Q1 June 2013. International revenues rose 36% to Rs 733 crore in Q1 June 2014 over Q1 June 2013. Adjusting for currency movements, revenues grew by 27%.
Torrent Pharmaceuticals has manufacturing plants located at Indrad, Baddi and Sikkim, which have facilities to produce formulatons and bulk drugs. The plant are approved by authorities from various regulated and semi-regulated markets like US, UK, Brazil, Germany, Australia and South Africa,
Powered by Capital Market - Live News
